| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2026―Apr―02 |
Severity and duration of immune response in people of different age categories after SARS-CoV-2 revaccination |
O. M. Drapkina, S. A. Berns, M. G. Chashchin, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova |
| 2 |
[GO] |
2026―Apr―02 |
Potential of electrocardiogram contour analysis in predicting severe coronavirus disease 2019 |
E. O. Ryadnova, V. P. Kitsyshin |
| 3 |
[GO] |
2026―Jan―23 |
Role of biobanks in studying frequencies of alleles associated with COVID-19 severity and outcome in the Russian population |
S. V. Apalko, V. S. Shimansky, O. S. Popov, N. N. Sushentseva, S. V. Mosenko, A. Yu. Asinovskaya, S. G. Shcherbak |
| 4 |
[GO] |
2026―Jan―23 |
Using a population biobank to analyze genogeographic variability in Russia and globally for three polymorphisms associated with severe COVID-19 |
E. V. Balanovskaya, M. M. Voronina, G. Yu. Ponomarev, I. O. Gorin, A. L. Borisova, M. S. Pokrovskaya, S. M. Koshel, E. A. Pocheshkhova, D. S. Adamov |
| 5 |
[GO] |
2025―Dec―03 |
A patient with overweight or obesity: lessons from COVID-19 pandemic (EVA observational study data) |
Yu. V. Lukina, O. V. Lerman, N. P. Kutishenko, S. Yu. Martsevich, O. M. Drapkina on behalf of the EVA study working group# |
| 6 |
[GO] |
2025―Aug―18 |
Potential of electrocardiogram contour analysis in predicting severe coronavirus disease 2019 |
E. O. Ryadnova, V. P. Kitsyshin |
| 7 |
[GO] |
2025―Jul―16 |
COVID-19 and vaping in Russia: how are hospitalizations, course and outcomes of coronavirus infection related to e-cigarette use? |
M. G. Gambaryan, M. G. Chashchin, A. V. Kontsevaya, O. M. Drapkina |
| 8 |
[GO] |
2025―May―17 |
Conventional (D-dimer) and potential (pentraxin 3 and sST2) biomarkers in long-term prognosis of adverse cardiovascular events in COVID-19 survivors without significant cardiovascular diseases |
T. V. Kanaeva, N. A. Karoli |
| 9 |
[GO] |
2025―Mar―09 |
COVID-19 and smoking in Russia: how are hospitalizations, course, and outcomes of coronavirus infection related to tobacco use? |
M. G. Gambaryan, M. G. Chashchin, A. V. Kontsevaya, A. Yu. Gorshkov, O. M. Drapkina |
| 10 |
[GO] |
2025―Feb―17 |
Vaccination against the SARS-CoV-2 in individuals with comorbidities |
S A Berns, M G Chashсhin, A Yu Gorshkov, O V Zhdanova, L N Ryzhakova, O A Litinskaya, O M Drapkina |
| 11 |
[GO] |
2025―Feb―17 |
COVID-19 incidence after vaccination with different types of vaccines against SARS-CoV-2 |
O. M. Drapkina, S. A. Berns, M. G. Chashсhin, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova, O. A. Litinskaya, M. S. Pokrovskaya |
| 12 |
[GO] |
2024―Nov―26 |
Associations of levels of biochemical markers of chronic and acute inflammation, abdominal obesity and post-COVID syndrome in COVID-19 convalescents |
A. A. Karaseva, A. D. Afanaseva, E. V. Garbuzova, E. V. Kashtanova, Ya. V. Polonskaya, V. S. Shramko, I. I. Logvinenko, Yu. I. Ragino |
| 13 |
[GO] |
2024―Feb―26 |
Has COVID-19 affected regional mortality from acute coronary artery disease? (comparison of two periods of 2017-2019 and 2020-2022) |
I. V. Samorodskaya, M. G. Bubnova, O. A. Akulova |
| 14 |
[GO] |
2024―Feb―09 |
Severity and duration of immune response in people of different age categories after SARS-CoV-2 revaccination |
O. M. Drapkina, S. A. Berns, M. G. Chashchin, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova |
| 15 |
[GO] |
2024―Feb―09 |
Booster vaccination against the SARS-CoV-2: mechanisms and efficiency |
S. A. Berns, A. V. Veremeyev, A. A. Savicheva, A. Yu. Gorshkov, O. M. Drapkina |
| 16 |
[GO] |
2024―Feb―02 |
Obesity in the Russian population during the COVID-19 pandemic and associated factors. Data from the ESSE-RF3 study |
Yu. A. Balanova, O. M. Drapkina, V. A. Kutsenko, A. E. Imaeva, A. V. Kontsevaya, S. A. Maksimov, G. A. Muromtseva, M. B. Kotova, N. S. Karamnova, S. E. Evstifeeva, A. V. Kapustina, O. A. Litinskaya, M. S. Pokrovskaya, S. O. Kuzyakina, O. E. Ivlev, L. I. Gomanova, Yu. V. Doludin, I. A. Efimova, A. L. Borisova, B. M. Nazarov, E. B. Yarovaya, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, E. N. Chernysheva, S. V. Glukhovskaya, I. F. Levina, T. F. Shirshova, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovyova, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, I. V. Tantsyreva, I. N. Baryshnikova, M, G. Ataev, M. O. Radjabov, M. M. Isakhanova, M. A. Umetov, L. V. Elgarova, E. A. Khakuasheva, E. I. Yamashkina, M. V. Esina, T. A. Kunyaeva, A. M. Nikitina, N. V. Savvina, Yu. E. Spiridonova, E. A. Naumova, A. A. Keskinov, V. S. Yudin, S. M. Yudin, S. A. Shalnova |
| 17 |
[GO] |
2024―Feb―02 |
Hypertension in the Russian population during the COVID-19 pandemic: sex differences in prevalence, treatment and its effectiveness. Data from the ESSE-RF3 study |
Yu. A. Balanova, O. M. Drapkina, V. A. Kutsenko, A. E. Imaeva, A. V. Kontsevaya, S. A. Maksimov, G. A. Muromtseva, M. B. Kotova, N. S. Karamnova, S. E. Evstifeeva, A. V. Kapustina, O. A. Litinskaya, M. S. Pokrovskaya, E. M. Filichkina, O. E. Ivlev, L. I. Gomanova, Yu. V. Doludin, I. A. Efimova, A. L. Borisova, B. M. Nazarov, E. B. Yarovaya, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, E. N. Chernysheva, S. V. Glukhovskaya, I. A. Levina, E. A. Shirshova, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovyova, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, I. V. Tantsyreva, I. N. Baryshnikova, M. G. Ataev, M. O. Radjabov, M. M. Isakhanova, M. A. Umetov, L. V. Elgarova, I. A. Khakuasheva, E. I. Yamashkina, M. V. Esina, T. A. Kunyaeva, A. M. Nikitina, N. V. Savvina, Yu. E. Spiridonova, E. A. Naumova, A. A. Keskinov, D. A. Kashtanova, V. S. Yudin, S. M. Yudin, S. A. Shalnova |
| 18 |
[GO] |
2024―Feb―02 |
Levels and types of physical activity in Russia according to the ESSE-RF study: is there a trace of the COVID-19 pandemic? |
M. B. Kotova, S. A. Maksimov, S. A. Shalnova, A. V. Kontsevaya, Yu. A. Balanova, A. E. Imaeva, V. A. Kutsenko, G. A. Muromtseva, N. S. Karamnova, S. E. Evstifeeva, A. V. Kapustina, O. A. Litinskaya, M. S. Pokrovskaya, E. B. Yarovaya, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, E. N. Chernysheva, S. V. Glukhovskaya, I. A. Levina, E. A. Shirshova, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. D. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovyova, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, I. V. Tantsyreva, I. N. Baryshnikova, M. G. Ataev, M. O. Radjabov, M. M. Isakhanova, M. A. Umetov, L. V. Elgarova, I. A. Khakuasheva, E. I. Yamashkina, M. V. Esina, T. A. Kunyaeva, A. M. Nikitina, N. V. Savvina, Yu. E. Spiridonova, E. A. Naumova, A. A. Keskinov, V. S. Yudin, S. M. Yudin, O. M. Drapkina |
| 19 |
[GO] |
2024―Feb―02 |
Proportion of COVID-19 survivors in 2020-2022 in the Russian population (according to the ESSE-RF3 study) |
G. A. Muromtseva, S. A. Shalnova, V. A. Kutsenko, E. M. Filichkina, Yu. A. Balanova, S. E. Evstifeeva, A. E. Imaeva, A. V. Kapustina, N. S. Karamnova, M. B. Kotova, S. A. Maksimov, O. B. Shvabskaya, O. E. Ivlev, A. A. Zelenina, L. I. Gomanova, E. B. Yarovaya, A. V. Kontsevaya, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, Z. N. Chernysheva, S. V. Glukhovskaya, I. A. Levina, E. A. Shirshova, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovyova, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, I. V. Tantsyreva, I. N. Baryshnikova, M. G. Ataev, M. O. Radzhabov, M. M. Isakhanova, M. A. Umetov, L. V. Elgarova, I. A. Khakuasheva, E. I. Yamashkina, M. V. Esina, T. A. Kunyaeva, A. M. Nikitina, N. V. Savvina, Yu. E. Spiridonova, E. A. Naumova, A. A. Keskinov, V. S. Yudin, S. M. Yudin, D. A. Kashtanova, M. S. Gusakova, O. M. Drapkina |
| 20 |
[GO] |
2024―Feb―02 |
Adherence to a healthy lifestyle in Russia according to the ESSE-RF study: is there a COVID-19 trace? |
О. M. Drapkina, M. B. Kotova, S. A. Maksimov, S. A. Shalnova, Yu. A. Balanova, A. E. Imaeva, V. A. Kutsenko, G. A. Muromtseva, N. S. Karamnova, S. E. Evstifeeva, A. V. Kapustina, O. A. Litinskaya, M. S. Pokrovskaya, E. B. Yarovaya, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, E. N. Chernysheva, S. V. Glukhovskaya, I. A. Levina, E. A. Shirshova, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V, Khokhlova, A. V. Solovyova, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, I. V. Tantsyreva, I. N. Baryshnikova, M. G. Ataev, M. O. Radjabov, M. M. Isakhanova, M. A. Umetov, L. V. Elgarova, I. A. Khakuasheva, E. I. Yamashkina, M. V. Esina, T. A. Kunyaeva, A. M. Nikitina, N. V. Savvina, Yu E. Spiridonova, E. A. Naumova, B. M. Nazarov, A. A. Keskinov, V. S. Yudin, S. M. Yudin, A. V. Kontsevaya |
| 21 |
[GO] |
2024―Feb―02 |
Alcohol consumption patterns in Russia according to the ESSE-RF study: is there a COVID-19 trace? |
S. A. Maksimov, S. A. Shalnova, Yu. A. Balanova, A. V. Kontsevaya, A. E. Imaeva, V. A. Kutsenko, G. A. Muromtseva, M. B. Kotova, N. S. Karamnova, S. E. Evstifeeva, A. V. Kapustina, O. A. Litinskaya, M. S. Pokrovskaya, E. B. Yarovaya, T. V. Repkina, T. O. Gonoshilova, A. V. Kudryavtsev, N. I. Belova, L. L. Shagrov, M. A. Samotrueva, A. L. Yasenyavskaya, E. N. Chernysheva, S. V. Glukhovskaya, I. A. Levina, E. A. Shirshova, E. B. Dorzhieva, E. Z. Urbanova, N. Yu. Borovkova, V. K. Kurashin, A. S. Tokareva, Yu. I. Ragino, G. I. Simonova, A. D. Khudyakova, V. N. Nikulin, O. R. Aslyamov, G. V. Khokhlova, A. V. Solovyova, A. A. Rodionov, O. V. Kryachkova, Yu. Yu. Shamurova, I. V. Tantsyreva, I. N. Baryshnikova, M. G. Ataev, M. O. Radjabov, M. M. Isakhanova, M. A. Umetov, L. V. Elgarova, I. A. Khakuasheva, E. I. Yamashkina, M. V. Esina, T. A. Kunyaeva, A. M. Nikitina, N. V. Savvina, Yu. E. Spiridonova, A. Keskinov, A. Yu. Yakovchik, V. S. Yudin, S. M. Yudin, O. M. Drapkina |
| 22 |
[GO] |
2023―Dec―11 |
Study of the metabolome features of patients with COVID-19 |
Y. V. Russkikh, N. N. Sushentseva, O. S. Popov, S. V. Apalko, A. Yu. Anisenkova, S. V. Mosenko, A. M. Sarana, S. G. Shcherbak |
| 23 |
[GO] |
2023―Nov―30 |
Two-year outcomes in patients after hospitalization for COVID-19: data from the TARGET-VIP registry |
M. M. Lukyanov, E. Yu. Andreenko, S. Yu. Martsevich, N. P. Kutishenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Pulin, А. А. Smirnov, V. G. Klyashtorny, O. E. Karpov, O. M. Drapkina |
| 24 |
[GO] |
2023―Nov―30 |
Analysis of the humoral and cell-mediated immune response in heterologous and homologous SARS-CoV-2 revaccination |
O. M. Drapkina, M. G. Chashchin, S. A. Berns, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova, O. A. Litinskaya |
| 25 |
[GO] |
2023―Nov―01 |
Heart rate variability in patients with acute ST-segment elevation myocardial infarction after COVID-19 |
V. P. Mikhin, O. A. Osipova, A. I. Gindler, A. S. Brizhaneva, N. V. Zaikina, M. P. Zaikina, T. A. Nikolenko, V. V. Savelyeva, M. A. Chernyatina |
| 26 |
[GO] |
2023―Nov―01 |
Changes of clinical and echocardiographic parameters within a year after COVID-19 pneumonia in patients without cardiovascular diseases, depending on the obesity presence |
E. I. Yaroslavskaya, N. E. Shirokov, D. V. Krinochkin, V. D. Garanina, I. O. Korovina, N. A. Osokina, A. V. Migacheva, A. D. Sapozhnikova, T. I. Petelina |
| 27 |
[GO] |
2023―Jul―21 |
Short- and long-term outcomes of patients with COVID-19 and acute kidney injury |
Yu. V. Khruleva, M. A. Efremovtseva, Yu. A. Timofeeva, M. V. Vatsik-Gorodetskaya, Zh. D. Kobalava |
| 28 |
[GO] |
2023―Jun―22 |
Structural and functional properties of arteries in COVID-19 survivors |
V. E. Oleinikov, I. V. Avdeeva, K. N. Polezhaeva, K. I. Pavlenko, N. A. Borisova, A. A. Khromova, A. V. Kulyutsin |
| 29 |
[GO] |
2023―Apr―11 |
Relationship between latent left ventricular contractile dysfunction and signs of immune inflammation in patients with COVID-19 pneumonia |
N. E. Shirokov, E. I. Yaroslavskaya, D. V. Krinochkin, N. A. Musikhina, T. I. Petelina, N. A. Osokina |
| 30 |
[GO] |
2023―Mar―11 |
Telemedicine technologies in improving the effectiveness of follow-up monitoring of patients with lower extremity peripheral artery disease during the COVID-19 pandemic |
S. A. Makarov, K. V. Smirnov, Ya. V. Danilchenko |
| 31 |
[GO] |
2023―Mar―11 |
Mitral valve chordal rupture against the background of cardiac SARS-CoV-2 infection. Cases series |
Z. N. Sukmarova, L. A. Matskevich, Yu. V. Ovchinnikov, O. I. Goloshchapov, A. M. Lila |
| 32 |
[GO] |
2023―Jan―19 |
Changes in NT-proBNP levels in patients with sinus tachycardia after COVID-19 |
V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, T. S. Vargina, E. S. Ogibenina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov |
| 33 |
[GO] |
2023―Jan―19 |
Medical treatment of patients with cardiovascular diseases during the first year after hospitalization for COVID-19 |
N. P. Kutishenko, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, А. А. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina |
| 34 |
[GO] |
2023―Jan―19 |
Detection rate and characteristics of heart failure, depending on the diagnostic criteria in COVID-19 survivors one year after hospitalization |
Yu. V. Mareev, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. N. Makoveeva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, M. M. Kudryavtseva, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina |
| 35 |
[GO] |
2023―Jan―19 |
Reactogenicity of various COVID-19 vaccination regimens |
O. M. Drapkina, S. A. Berns, A. Yu. Gorshkov, L. N. Ryzhakova, O. V. Zhdanova, M. G. Chaschin, O. A. Litinskaya |
| 36 |
[GO] |
2023―Jan―19 |
Comparative assessment of the immunogenicity of various revaccination regimens against the SARS-CoV-2 |
O. M. Drapkina, S. A. Berns, A. Yu. Gorshkov, L. N. Ryzhakova, O. V. Zhdanova, M. G. Chaschin, O. A. Litinskaya, A. A. Savicheva, M. S. Pokrovskaya |
| 37 |
[GO] |
2022―Nov―05 |
Effect of spironolactone therapy on the activity of the matrix metalloproteinase system in patients with heart failure after COVID-19 |
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, А. A. Ivannikov, S. S. Khanakyan, A. M. Almyasheva |
| 38 |
[GO] |
2022―Sep―08 |
Comparison of inhospital outcomes after open thrombectomy versus conservative therapy in patients with acute lower limb artery thrombosis and COVID-19 |
I. A. Abdullaev, S. V. Abasova, L. B. Danilchuk, V. A. Shramko, E. V. Sokolova, A. V. Korotkikh, A. S. Zharova, R. V. Kokaya, A. N. Kazantsev |
| 39 |
[GO] |
2022―Aug―11 |
Comparative efficacy of ivabradine and beta-blockers in the treatment of tachycardia in patients after COVID-19 |
V. I. Podzolkov, A. E. Bragina, A. I. Tarzimanova, E. S. Ogibenina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov |
| 40 |
[GO] |
2022―Aug―11 |
Features of the pathogenesis and course of myocardial infarction in COVID-19 patients: a descriptive review |
M. G. Chashchin, A. Yu. Gorshkov, A. V. Strelkova, O. M. Drapkina |
| 41 |
[GO] |
2022―Jul―24 |
Assessment of the quality of research and practice events using telemedicine technologies at the National Medical Research Center for Therapy and Preventive Medicine during the COVID-19 pandemic |
O. M. Drapkina, R. N. Shepel, S. Yu. Astanina, T. V. Vakhovskaya, T. V. Sapronova, T. V. Samoilov |
| 42 |
[GO] |
2022―Jul―09 |
Russian-language publication activity of medical researchers in during the COVID-19 pandemic: “post-COVID-19 syndrome” |
O. T. Kim, O. M. Drapkina, Yu. V. Rodionova |
| 43 |
[GO] |
2022―Jul―09 |
New SARS-CoV-2 Omicron variant - clinical picture, treatment, prevention (literature review) |
V. I. Vechorko, O. V. Averkov, A. A. Zimin |
| 44 |
[GO] |
2022―Apr―07 |
Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial |
I. S. Yavelov |
| 45 |
[GO] |
2022―Mar―28 |
Place of renin-angiotensin-aldosterone system inhibitors and statins in the treatment of cardiovascular patients in the context of COVID-19 pandemic |
E. V. Sayutina, L. I. Butorova, E. M. Tuaeva, M. A. Osadchuk, M. M. Shamuilova |
| 46 |
[GO] |
2022―Mar―28 |
NEWS2, 4C Mortality Score, COVID-GRAM, Sequential Organ Failure Assessment Quick scales as outcomes assessment tools for severe COVID-19 (pilot retrospective cohort study) |
V. I. Vechorko, O. V. Averkov, D. V. Grishin, A. A. Zimin |
| 47 |
[GO] |
2022―Feb―28 |
Health care quality and changes in the clinical characteristics of patients with non-ST elevation acute coronary syndrome in a regional vascular center during the COVID-19 pandemic |
S. V. Dil, S. V. Demyanov, V. V. Ryabov, S. V. Popov |
| 48 |
[GO] |
2022―Feb―28 |
Use of non-steroidal anti-inflammatory drugs during the COVID-19 pandemic. Resolution of the Expert Council of the Russian Society for the Prevention of Noncommunicable Diseases |
O. M. Drapkina, S. N. Avdeev, A. V. Gorelov, V. P. Chulanov, L. I. Alekseeva, A. B. Danilov, G. R. Tabeeva, M. V. Pchelintsev |
| 49 |
[GO] |
2022―Feb―28 |
Effusive pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a case series |
Z. N. Sukmarova, M. A. Saidova, Yu. V. Ovchinnicov |
| 50 |
[GO] |
2022―Feb―28 |
Additional evidence against widespread use of inpatient antiplatelet therapy in coronavirus infection: data from a randomized controlled trial |
I. S. Yavelov |
| 51 |
[GO] |
2022―Jan―12 |
The possibilities of using antiplatelet agents during and after COVID-19 disease. Results of the Expert Council meeting |
Article Editorial |
| 52 |
[GO] |
2022―Jan―12 |
Dynamics of age characteristics and prevalence of concomitant cardiovascular and non-sardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave: data from TARGET-VIP registry |
M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelny, A. N. Makoveeva, O. V. Lerman, E. Yu. Okshina, А. S. Sgibneva, A. A. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina |
| 53 |
[GO] |
2022―Jan―12 |
The outpatient medical care in patients with chronic diseases under dispensary supervision in the conditions of the COVID-19 pandemic. Temporary guidelines. Version 2 |
O. M. Drapkina, L. Y. Drozdova, S. N. Avdeev, S. A. Boytsov, E. S. Ivanova, А. D. Kaprin, T. A. Kunaeva, Е. A. Lavrenova, M. A. Liusan, I. V. Maev, J. S. Rakowskaya, I. V. Samorodskaya, А. I. Chesnikova, R. N. Shepel |
| 54 |
[GO] |
2021―Nov―28 |
Association of COVID-19 lockdown measures with changes in physical activity of the adult population of Russia |
D. K. Mukaneeva, A. V. Kontsevaya, A. A. Antsiferova, I. N. Khalfiev, A. A. Seledtsov, E. A. Stolyarova, A. V. Solovieva, M. V. Popovich, L. Yu. Drozdova, O. M. Drapkina |
| 55 |
[GO] |
2021―Nov―28 |
Clinical and anamnestic characteristics of patients with non-ST elevation myocardial infarction after COVID-19 |
M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina, I. V. Kositsyna, A. V. Golubev, N. I. Chaus, S. N. Perekhodov |
| 56 |
[GO] |
2021―Oct―16 |
Hydrogen inhalation in rehabilitation program of the medical staff recovered from COVID-19 |
L. V. Shogenova, Thi Tuet Truong, N. O. Kryukova, K. A. Yusupkhodzhaeva, D. D. Pozdnyakova, T. G. Kim, A. V. Chernyak, Е. N. Kalmanova, O. S. Medvedev, T. A. Kuropatkina, S. D. Varfolomeev, A. M. Ryabokon, O. А. Svitich, M. P. Kostinov, Ibaraki Kunio, Maehara Hiroki, A. G. Chuchalin |
| 57 |
[GO] |
2021―Oct―16 |
Single-center register of myocardial revascularization in patients with coronary artery disease and acute coronary syndrome in the context of COVID-19 pandemic |
O. V. Kamenskaya, A. S. Klinkova, I. Yu. Loginova, V. N. Lomivorotov, A. M. Chernyavskiy, V. V. Lomivorotov |
| 58 |
[GO] |
2021―Sep―12 |
COVID-19 as a cause of chronic pulmonary hypertension: pathophysiological rationale and potential of instrumental investigations |
E. Kobelev, T. A. Bergen, A. R. Tarkova, O. Ya. Vasiltseva, O. V. Kamenskaya, V. Yu. Usov, A. M. Chernyavsky |
| 59 |
[GO] |
2021―Sep―12 |
Acute coronary syndrome in COVID-19 patients |
M. G. Chashchin, A. Yu. Gorshkov, O. M. Drapkina |
| 60 |
[GO] |
2021―Jul―18 |
Thrombectomy vs conservative therapy in patients with COVID-19 |
A. N. Kazantsev |
| 61 |
[GO] |
2021―Jul―18 |
COVID-19 and cardiovascular comorbidity: novel approaches to reduce mortality |
S. S. Bunova, P. I. Okhotnikova, Yu. P. Skirdenko, N. A. Nikolaev, O. A. Osipova, N. I. Zhernakova |
| 62 |
[GO] |
2021―Jul―18 |
Algorithms for adult outpatient care of coronavirus disease 2019 (COVID-19) and its Assumption |
M. A. Livzan, O. M. Drapkina, N. A. Nikolaev, Y. P. Skirdenko, R. N. Shepel, I. A. Viktorova, M. V. Kuznetsova, A. V. Mordyk, K. A. Andreev, V. G. Berezhnoy, M. V. Vershinina, A. V. Gorbenko, I. V. Druk, O. Yu. Korennova, M. B. Kostenko, A. V. Lisichkina, E. V. Nadey, N. V. Ovsyannikov, L. V. Puzyreva, I. M. Tolokh, M. M. Fedorin |
| 63 |
[GO] |
2021―Jul―18 |
Acute lower limb ischemia in the context of the COVID-19 pandemic |
I. A. Vinokurov |
| 64 |
[GO] |
2021―Jul―18 |
Surgical thrombectomy versus conservative treatment in cases of acute limb ischemia with COVID-19 pneumonia |
A. M. Fahad, H. A. Alkhalidi, Y. Q. M. Altimimi |
| 65 |
[GO] |
2021―Jul―18 |
Mehman Mamedov: case management during and after coronavirus pandemic |
Article Editorial |
| 66 |
[GO] |
2021―May―15 |
COVID-19 from the interdisciplinary standpoint. Round table |
M. N. Mamedov, Yu. V. Rodionova, I. S. Yavelov, M. I. Smirnova, E. N. Dudinskaya, V. I. Potievskaya |
| 67 |
[GO] |
2021―May―15 |
Proteolytic enzyme and adiponectin receptors as potential targets for COVID-19 therapy |
K. A. Rubina, N. R. Sabitova, A. Yu. Efimenko, N. I. Kalinina, J. A. Akopyan, E. V. Semina |
| 68 |
[GO] |
2021―Feb―20 |
Clinical and laboratory characteristics of patients with COVID-19 and concomitant type 2 diabetes |
T. Yu. Demidova, K. G. Lobanova, S. N. Perekhodov, M. B. Antsiferov, O. Sh. Oynotkinova |
| 69 |
[GO] |
2020―Dec―31 |
COVID-19 biobank: features of the cytokine profile |
N. N. Sushentseva, O. S. Popov, S. V. Apalko, A. Yu. Anisenkova, S. V. Azarenko, K. V. Smantserev, D. N. Khobotnikov, T. V. Gladysheva, E. V. Minina, S. V. Strelyukhina, S. P. Urazov, D. Pavlovich, S. R. Fridman, S. G. Shcherbak |
| 70 |
[GO] |
2020―Dec―31 |
Prospective in-hospital registry of patients with suspected or documented COVID-19 infection and community-acquired pneumonia (TARGET-VIP): characteristics of patients and assessment of in-hospital outcomes |
O. M. Drapkina, O. E. Karpov, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, V. G. Akimkin, E. Yu. Andrenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelny, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, E. V. Kudryashov, V. G. Klyashtorny, A. A. Smirnov, V. S. Fomina |
| 71 |
[GO] |
2020―Dec―31 |
Work within the COVID-19 pandemic - the experience of the biobank of the National Medical Research Center of Oncology |
I. V. Samokhina, A. B. Sagakyants |
| 72 |
[GO] |
2020―Jul―03 |
Debatable points of using angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in patients with COVID-19 |
O. M. Drapkina, L. E. Vasilyeva |
| 73 |
[GO] |
2020―Jul―03 |
COVID-19 and nutrition: new emphases, old priorities (review of guidelines) |
N. S. Karamnova, O. M. Drapkina |
| 74 |
[GO] |
2020―Jul―03 |
Health promotion and prevention of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases |
O. M. Drapkina, M. G. Gambaryan, B. E. Gorny, N. S. Karamnova, A. V. Kontsevaya, N. K. Novikova, M. V. Popovich, I. A. Rybakov, A. M. Kalinina |
| 75 |
[GO] |
2020―Jul―03 |
Tobacco smoking and COVID-19: an old enemy in a new guise. Review of current publications |
M. G. Gambaryan, O. M. Drapkina |
| 76 |
[GO] |
2020―Jul―03 |
COVID-19: urgent questions for estimating morbidity, prevalence, case fatality rate and mortality rate |
O. M. Drapkina, I. V. Samorodskaya, M. G. Sivtseva, E. P. Kakorina, N. I. Briko, S. N. Cherkasov, V. A. Zinserling, P. G. Malkov |
| 77 |
[GO] |
2020―Jul―03 |
Novel coronavirus infection SARS-CoV-2 in elderly and senile patients: prevention, diagnosis and treatment. Expert Position Paper of the Russian Association of Gerontology and Geriatrics |
O. N. Tkacheva, Yu. V. Kotovskaya, L. A. Aleksanyan, A. S. Milto, A. V. Naumov, I. D. Strazhesko, N. M. Vorobyeva, E. N. Dudinskaya, I. P. Malaya, K. Yu. Krylov, E. A. Tyukhmenev, A. V. Rozanov, V. S. Ostapenko, T. M. Manevich, A. Yu. Shchedrina, F. A. Semenov, E. A. Mkhitaryan, N. O. Khovasova, K. A. Yeruslanova, N. V. Kotovskaya, N. V. Sharashkina |
| 78 |
[GO] |
2020―Jun―25 |
Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020 |
V. B. Grinevich, I. V. Gubonina, V. L. Doshchitsin, Yu. V. Kotovskaya, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, A. V. Syrov, A. V. Tarasov, A. I. Tarzimanova, O. N. Tkacheva, D. I. Trukhan |
| 79 |
[GO] |
2020―May―11 |
Self-monitoring and treatment of chronic non-communicable diseases in the context of the COVID-19 pandemic. Consensus of experts of the National society of evidence-based pharmacotherapy and the Russian society of the prevention of non-communicable diseases |
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, L. P. Ivanova, N. A. Dmitrieva, A. V. Kontsevaya, O. M. Drapkina |
| 80 |
[GO] |
2020―May―11 |
COVID-19: hemostatic parameters and specifics of antithrombotic treatment |
I. S. Yavelov, O. M. Drapkina |
|
